Lv53
890 积分 2023-12-12 加入
Kupffer cell calibration of T cell responses via VSIG4–CD5 interaction promotes tumor evasion
1个月前
已完结
Targeting the PRMT5-CBX8 axis overcomes dual barriers of CD8⁺ T cell exclusion and tumor stemness for sensitizing TNBC to anti-PD-1 therapy
1个月前
已完结
Generation of membrane-permeable cyclic peptides inhibiting protein–protein interaction
2个月前
已完结
Macrocyclic peptides as protein–protein interaction modulators: a review
2个月前
已完结
Discovery and development of small-molecule inhibitors targeting cytotoxic T lymphocyte associated protein 4 to enhance cancer immunotherapy and reduce side effects
2个月前
已完结
BPS2026 – A systematic framework for peptide-based inhibition of SHP2 protein-protein interactions
2个月前
已关闭
The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer
2个月前
已完结
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment
2个月前
已完结
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction
2个月前
已完结
Computational Design of a Bicyclic Peptide Inhibitor Targeting the ICOS/ICOS-L Protein–Protein Interaction
2个月前
已完结
皖公网安备34019202002308
